GASL-Preis der YAEL Stiftung

Der GASL-Preis der YAEL-Stiftung wird anlässlich der Jahrestagung der GASL verliehen und ist mit jährlich 3000 Euro ausgestattet.
Der Preis wird vom Vorstand und dem Programmkomitee der GASL aus den besten publizierten Leistungen des zurückliegenden Jahres bei der Sitzung des Vorstandes und Programmkomitees im Oktober ausgewählt.

Preisträger 2018

Dr. Abdo Mahli

Dr. Abdo Mahli

Academic Career
2016-current: Scientific Assistent at the Institute of Biochemistry, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany
2014-2016: Scientific Researcher (PostDoc) at the Department of Internal Medicine I, Regensburg University Hospital, Regensburg, Germany
2009-2013: PhD Student in the Department of Internal Medicine I at the University Hospital Regensburg in the Work group of Prof.Dr.med. Claus Hellerbrand (thesis defense to obtain Dr. rer. nat. degree in Dec 2013; rate: magna cum laude)

Education
2002-2007: Study of Pharmacy and Pharmaceutical Chemistry, University of Aleppo, Major: Pharmaceutical industry, Minors: botany and biochemistry (diploma in July 2007; rate: very good)

Awards
1. EASL Young Investigator Bursary (Full Bursary), (European Association for the Study of the Liver), Vienna, Austria (18-22.April.2015)
2. EASL Young Investigator Bursary (Registration Bursary), (European Association for the Study of the Liver), Barcelona, Spain (18-22.April.2012)
3. Travel Awards from Falk workshop for the Years (2012, 2013, 2014, 2016 and 2017)

Selected publications (with Dr. Mahli as first or corresponding author)
Original publications:
Mahli A, Saugspier M, Koch A, Sommer J, Dietrich P, Lee S, Thasler R, Schulze-Luehrmann J, Luehrmann A, Thasler WE, Müller M, Bosserhoff A, Hellerbrand C. (2017), ERK activation and autophagy impairment are central mediators of irinotecan-induced steatohepatitis.
Gut.pii: gutjnl-2016-312485. doi: 10.1136/gutjnl-2016-312485. [Epub ahead of print].

Sommer J 2, Mahli A 2, Freese K, Schiergens TS, Kuecuekoktay FS, Teufel A, Thasler WE, Müller M, Bosserhoff AK, Hellerbrand C. (2016), Analysis of molecular mechanisms of 5-fluorouracil-induced steatosis and inflammation in vitro and in mice.
Oncotarget. 2016 Dec 30. doi: 10.18632/oncotarget.14371. 2: equal contribution.

Mahli A, Thasler WE, Patsenker E, Müller S, Stickel F, Müller M, Seitz HK, Cederbaum AI, Hellerbrand C. (2015), Identification of cytochrome CYP2E1 as critical mediator of synergistic effects of alcohol and cellular lipid accumulation in hepatocytes in vitro. Oncotarget. 2015 Dec 8;6(39):41464-78. doi: 10.18632/oncotarget.6203.

Mahli A, Koch A, Czech B, Peterburs P, Lechner A, Haunschild J, Müller M and Hellerbrand C. (2015), Hepatoprotective effect of oral application of a silymarin extract in carbon tetrachloride-induced hepatotoxicity in rats.
Clinical PhytoscienceInternational Journal of Phytomedicine and Phytotherapy20151:5 DOI: 10.1186/s40816-015-0006-z.

Mahli A, Koch A, Freese K, Thasler WE, Bergheim I, Schönberger C, Bosserhoff A, Hellerbrand C.
Iso-Alpha Acids (IAA) from hops (Humulus lupulus) inhibit hepatic steatosis, inflammation and fibrosis (submitted).

Reviews:
Mahli A, Hellerbrand C. Alcohol and Obesity: A Dangerous Association for Fatty Liver Disease. Dig Dis. 2016;34 Suppl 1:32-9. doi: 10.1159/000447279.

Weiskirchen R 2, Mahli A 2, Weiskirchen S, Hellerbrand C. The hop constituent xanthohumol exhibits hepatoprotective effects and inhibits the activation of hepatic stellate cells at different levels. Front Physiol. 2015 May 6;6:140.doi:10.3389/fphys.2015.00140. 2: equal contribution.

 

 

Preisträger 2017

 

Preisträgerin 2016

 

Preisträger 2015

 

Preisträgerin 2014

 

Preisträgerin 2013

 

Preisträger 2012

 

Preisträgerin 2011

 

Preisträgerin 2010

 

Preisträger 2009